On January 2019, Natco Pharma has launched a cardiac drug Valsartan-Sacubitril tablet at an affordable price, under its brand VALSAC in India. VALSAC (Valsartan Sacubitril) is a combination heart drug…. Continue Reading
Natco Pharma applying for generic version of ibrutinib cancer drug
Indian leading generic drug manufacturer, Natco pharma submits the generic version of ibrutinib drug approval application to USFDA. The strength would be 140 mg, 280 mg, 420 mg and 560… Continue Reading
The Medicines Patent Pool signed a license to expand access to hepatitis C treatment, Glecaprevir / Pibrentasvir
On 12 November 2018 – The Medicines Patent Pool (MPP) has announced a new, royalty-free licence agreement with AbbVie for Glecaprevir / Pibrentasvir (G/P). The agreement was launched at the… Continue Reading
Cipla gets Approval for Valcyte Generic Valganciclovir 450 mg Tablets
On 12th November 2018, the United States Food and Drugs Administration (US FDA) has provided the final approval to the Cipla Limited’s Valganciclovir 450mg Tablets, the generic version of Roche… Continue Reading
Interferon-Free Generic Hep C Treatment Get 99% Cure
Old Interferon Hep C treatment: Interferon was discovered early. Interferon is mainly a protein which is released by the cells. When the body gets attack from a virus then the… Continue Reading